Literature DB >> 34299300

The Role of PI3K/AKT and MAPK Signaling Pathways in Erythropoietin Signalization.

Zuzana Tóthová1, Martina Šemeláková1, Zuzana Solárová2, Jana Tomc3, Nataša Debeljak3, Peter Solár1.   

Abstract

Erythropoietin (EPO) is a glycoprotein cytokine known for its pleiotropic effects on various types of cells and tissues. EPO and its receptor EPOR trigger signaling cascades JAK2/STAT5, MAPK, and PI3K/AKT that are interconnected and irreplaceable for cell survival. In this article, we describe the role of the MAPK and PI3K/AKT signaling pathways during red blood cell formation as well as in non-hematopoietic tissues and tumor cells. Although the central framework of these pathways is similar for most of cell types, there are some stage-specific, tissue, and cell-lineage differences. We summarize the current state of research in this field, highlight the novel members of EPO-induced PI3K and MAPK signaling, and in this respect also the differences between erythroid and non-erythroid cells.

Entities:  

Keywords:  MAPK; PI3K; erythropoietin

Year:  2021        PMID: 34299300     DOI: 10.3390/ijms22147682

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  8 in total

1.  Insilco and Invitro approaches identify novel dual PI3K/AKT pathway inhibitors to control acute myeloid leukemia cell proliferations.

Authors:  Mohammad Abohassan; Mesfer Alshahrani; Mohammad Y Alshahrani; Prasanna Rajagopalan
Journal:  Med Oncol       Date:  2022-10-08       Impact factor: 3.738

Review 2.  Erythropoietin in Optic Neuropathies: Current Future Strategies for Optic Nerve Protection and Repair.

Authors:  Yi-Fen Lai; Ting-Yi Lin; Pin-Kuan Ho; Yi-Hao Chen; Yu-Chuan Huang; Da-Wen Lu
Journal:  Int J Mol Sci       Date:  2022-06-27       Impact factor: 6.208

Review 3.  Molecular Pathways Involved in the Development of Congenital Erythrocytosis.

Authors:  Jana Tomc; Nataša Debeljak
Journal:  Genes (Basel)       Date:  2021-07-28       Impact factor: 4.096

Review 4.  Targeting Stress Erythropoiesis Pathways in Cancer.

Authors:  Sanja Vignjević Petrinović; Aleksandra Jauković; Maja Milošević; Diana Bugarski; Mirela Budeč
Journal:  Front Physiol       Date:  2022-05-25       Impact factor: 4.755

5.  LncCDH5-3:3 Regulates Apoptosis, Proliferation, and Aggressiveness in Human Lung Cancer Cells.

Authors:  Konrad Kwaśniak; Justyna Czarnik-Kwaśniak; Khrystyna Malysheva; Katarzyna Pogoda; Olexandr Korchynskyi; Paweł Rybojad; Bożenna Karczmarek-Borowska; Jacek Tabarkiewicz
Journal:  Cells       Date:  2022-01-23       Impact factor: 6.600

6.  Phosphorylated ATF1 at Thr184 promotes metastasis and regulates MMP2 expression in gastric cancer.

Authors:  Tong Li; Huiyuan Cao; Sa Wu; Peimin Zhong; Jie Ding; Jing Wang; Fangfang Wang; Zhiwei He; Guo-Liang Huang
Journal:  J Transl Med       Date:  2022-04-09       Impact factor: 5.531

7.  Pan-Cancer Analysis Based on EPOR Expression With Potential Value in Prognosis and Tumor Immunity in 33 Tumors.

Authors:  Yajing Zhang; Senyu Wang; Songtao Han; Yangchun Feng
Journal:  Front Oncol       Date:  2022-03-14       Impact factor: 6.244

8.  Erythropoietin Activates Autophagy to Regulate Apoptosis and Angiogenesis of Periodontal Ligament Stem Cells via the Akt/ERK1/2/BAD Signaling Pathway under Inflammatory Microenvironment.

Authors:  Denghao Huang; Jie Lei; Xingrui Li; Zhonghao Jiang; Maoxuan Luo; Yao Xiao
Journal:  Stem Cells Int       Date:  2022-09-20       Impact factor: 5.131

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.